Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11894-020-00759-1.pdf
Reference66 articles.
1. Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol. 2015;27(1):24–31. https://doi.org/10.1097/bor.0000000000000125.
2. Lee HJ, Cheon JH. Optimal diagnosis and disease activity monitoring of intestinal Behcet’s disease. Intest Res. 2017;15(3):311–7. https://doi.org/10.5217/ir.2017.15.3.311.
3. Kim DH, Cheon JH. Intestinal Behcet’s disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis? Yonsei Med J. 2016;57(1):22–32. https://doi.org/10.3349/ymj.2016.57.1.22.
4. Arimoto J, Endo H, Kato T, Umezawa S, Fuyuki A, Uchiyama S, et al. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behcet’s disease. Dig Endosc. 2016;28(2):179–85. https://doi.org/10.1111/den.12552.
5. Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Clinical course of intestinal Behcet’s disease during the first five years. Dig Dis Sci. 2013;58(2):496–503. https://doi.org/10.1007/s10620-012-2351-9.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea;BMC Gastroenterology;2023-12-19
2. Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance;Autoimmunity Reviews;2023-08
3. The treatment principles and targets for intestinal Behcet’s disease;Therapeutic Advances in Gastroenterology;2023-01
4. Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN);Gut and Liver;2022-12-29
5. Indications and effects of biological agents in the treatment of noninfectious uveitis;Immunotherapy;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3